The Learning Portal will be under maintenance Friday, 28 January from 10PM to 12AM. Portal functionality may be unavailable intermittently during this window.
We apologize for any inconvenience caused during this time.

  • FDA Announces Safety Labeling Change for Statin Blockbusters

    The US Food and Drug Administration announced on 28 February that it is implementing "important safety changes to the labeling" of some of the most popular statin drugs on the market, including Lipitor, Crestor and Zocor. FDA announced four changes to the labeling for the statin products: FDA now recommends that liver enzyme tests should be performed before starting statin therapy, and as clinically indicated thereafter Certain cognitive (brain-related) effects have...